Amyloid‐PET disclosure in Subjective Cognitive Decline: patient experiences and outcomes over time
Heleen M.A. Hendriksen(MACOM (United States)), Wiesje M. van der Flier(Amsterdam Neuroscience), Leonie N.C. Visser(Utrecht University), Denise Visser(University Medical Center Utrecht), Elsmarieke van de Giessen(Amsterdam Neuroscience), Tanja J. de Rijke(GGD Amsterdam), Mardou S. S. A. van Leeuwenstijn(Amsterdam Neuroscience), Jetske van der Schaar(Amsterdam Neuroscience), Agnetha D. Fruijtier(Amsterdam UMC Location University of Amsterdam), Calvin Trieu(Amsterdam Neuroscience), Ellen M.A. Smets(Amsterdam University Medical Centers), Argonde C. van Harten(Amsterdam Neuroscience)
Cited by 1
Related Papers
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
|Alzheimer s & Dementia|2014|3.1k
Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk
|Nature Genetics|2019|2.5k
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations
|Journal of Neurology Neurosurgery & Psychiatry|2010|776